People in the biotech world have talked about Regeneron Pharmaceuticals (NASDAQ:REGN) for a long time. After all, the company has achieved a lot of success over the years.
But now, people all over the world are interested in Regeneron. Just look up the company's name as a search term on Google Trends. Searches about the biotech have skyrocketed in recent weeks. Why are so many talking about Regeneron these days? The company is at the forefront of developing potential treatments for coronavirus disease COVID-19.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,